Overview
Application of Multi-Component Liquid Biopsy (ctDNA, utDNA, Exosomes, and Protein Biomarkers in Blood and Urine) for Auxiliary Diagnosis, Therapeutic Response Evaluation, and Recurrence Monitoring in Urothelial Carcinoma
Eligibility
Inclusion Criteria:
- Suspected or histologically confirmed urothelial carcinoma
Exclusion Criteria:
- History of or concurrent active malignancy other than urothelial carcinoma


